Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
Outset Medical Inc (NASDAQ: OM) closed the day trading at $1.10 down -13.39% from the previous closing price of $1.27. In other words, the price has decreased by -$13.39 from its previous closing price. On the day, 3.71 million shares were traded. OM stock price reached its highest trading level at $1.36 during the session, while it also had its lowest trading level at $1.08.
Ratios:
For a better understanding of OM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.04 and its Current Ratio is at 6.49. In the meantime, Its Debt-to-Equity ratio is 4.23 whereas as Long-Term Debt/Eq ratio is at 4.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on August 08, 2024, Downgraded its rating to Sector Perform and sets its target price to $3 from $6 previously.
On June 21, 2024, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $5 to $6.
On April 08, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $6.BTIG Research initiated its Buy rating on April 08, 2024, with a $6 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 07 ’25 when Trigg Leslie sold 10,227 shares for $1.29 per share. The transaction valued at 13,193 led to the insider holds 894,624 shares of the business.
Nash Marc sold 720 shares of OM for $929 on Jan 07 ’25. The SVP Operations and R&D now owns 237,302 shares after completing the transaction at $1.29 per share. On Jan 07 ’25, another insider, Brottem John L., who serves as the General Counsel of the company, sold 1,572 shares for $1.29 each. As a result, the insider received 2,028 and left with 225,520 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OM now has a Market Capitalization of 58238180 and an Enterprise Value of 84247224. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.50 while its Price-to-Book (P/B) ratio in mrq is 1.21. Its current Enterprise Value per Revenue stands at 0.734 whereas that against EBITDA is -0.684.
Stock Price History:
Over the past 52 weeks, OM has reached a high of $5.67, while it has fallen to a 52-week low of $0.44. The 50-Day Moving Average of the stock is 15.87%, while the 200-Day Moving Average is calculated to be -45.21%.
Shares Statistics:
Over the past 3-months, OM traded about 876.95K shares per day on average, while over the past 10 days, OM traded about 1180840 shares per day. A total of 52.54M shares are outstanding, with a floating share count of 48.29M. Insiders hold about 8.10% of the company’s shares, while institutions hold 48.61% stake in the company. Shares short for OM as of 1734048000 were 2622190 with a Short Ratio of 2.99, compared to 1731628800 on 2896673. Therefore, it implies a Short% of Shares Outstanding of 2622190 and a Short% of Float of 5.83.
